Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer
- First Posted Date
- 2022-05-16
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Vitrac Therapeutics, LLC
- Target Recruit Count
- 3
- Registration Number
- NCT05374538
- Locations
- 🇺🇸
University of California Davis, Sacramento, California, United States
🇺🇸Yale Cancer Center, North Haven, Connecticut, United States
🇺🇸Emory University Winship Cancer Center, Atlanta, Georgia, United States
News
No news found